Terms: = Prostate cancer AND CARS, P49589, 833, ENSG00000110619
133 results:
1. Neighborhood Deprivation, Race and Ethnicity, and prostate cancer Outcomes Across California Health Care Systems.
Wadhwa A; Roscoe C; Duran EA; Kwan L; Haroldsen CL; Shelton JB; Cullen J; Knudsen BS; Rettig MB; Pyarajan S; Nickols NG; Maxwell KN; Yamoah K; Rose BS; Rebbeck TR; Iyer HS; Garraway IP
JAMA Netw Open; 2024 Mar; 7(3):e242852. PubMed ID: 38502125
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic profiling in tissues and urine of patients with prostatic lesions and the diagnostic value of urine extracellular vesicles metabolites in prostate cancer.
Ding T; He W; Yan H; Wei Z; Zeng X; Hao X
Clin Chim Acta; 2024 Mar; 556():117845. PubMed ID: 38403146
[TBL] [Abstract] [Full Text] [Related]
3. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy.
Hu C; Qiao X; Hu C; Cao C; Wang X; Bao J
Cancer Imaging; 2024 Feb; 24(1):23. PubMed ID: 38326860
[TBL] [Abstract] [Full Text] [Related]
4. Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study.
García Vicente AM; Lucas Lucas C; Pérez-Beteta J; Borrelli P; García Zoghby L; Amo-Salas M; Soriano Castrejón ÁM
Sci Rep; 2024 Feb; 14(1):3001. PubMed ID: 38321201
[TBL] [Abstract] [Full Text] [Related]
5. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.
Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
[TBL] [Abstract] [Full Text] [Related]
6. cancer incidence in Iran in 2016: A study based on the Iranian National cancer Registry.
Hadavandsiri F; Allahqoli L; Rahimi Y; Salehiniya H; Ghazanfari Savadkoohi E; Akbari ME
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1967. PubMed ID: 38148563
[TBL] [Abstract] [Full Text] [Related]
7. Perioperative, function, and positive surgical margin in extraperitoneal versus transperitoneal single port robot-assisted radical prostatectomy: a systematic review and meta-analysis.
Jiang Y; Liu Y; Qin S; Zhong S; Huang X
World J Surg Oncol; 2023 Dec; 21(1):383. PubMed ID: 38087327
[TBL] [Abstract] [Full Text] [Related]
8. Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function.
Jain N; Zhao Z; Koche RP; Antelope C; Gozlan Y; Montalbano A; Brocks D; Lopez M; Dobrin A; Shi Y; Gunset G; Giavridis T; Sadelain M
Cancer Discov; 2024 Jan; 14(1):142-157. PubMed ID: 37934007
[TBL] [Abstract] [Full Text] [Related]
9. Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer.
Sayadmanesh A; Yekehfallah V; Valizadeh A; Abedelahi A; Shafaei H; Shanehbandi D; Basiri M; Baradaran B
Int Immunopharmacol; 2023 Dec; 125(Pt A):111093. PubMed ID: 37897950
[TBL] [Abstract] [Full Text] [Related]
10. Patient-related characteristics predict prostate cancers in men with PI-RADS 4-5 to further optimize the diagnostic performance of MRI.
Xiang L; Ma S; Xu Y; Jiang L; Guo H; Liu H; Liu Y
Abdom Radiol (NY); 2023 Dec; 48(12):3766-3773. PubMed ID: 37776336
[TBL] [Abstract] [Full Text] [Related]
11. F77 antigen is a promising target for adoptive T cell therapy of prostate cancer.
Grover P; Nunez-Cruz S; Leferovich J; Wentz T; Bagchi A; Milone MC; Greene MI
Biochem Biophys Res Commun; 2023 Nov; 680():51-60. PubMed ID: 37717341
[TBL] [Abstract] [Full Text] [Related]
12. Growing Deficit in New cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study.
Englum BR; Sahoo S; Mayorga-Carlin M; Hayssen H; Siddiqui T; Turner DJ; Sorkin JD; Lal BK
Ann Surg Oncol; 2023 Dec; 30(13):8509-8518. PubMed ID: 37695458
[TBL] [Abstract] [Full Text] [Related]
13. Self-removal of catheter after robot-assisted radical prostatectomy: a feasibility study.
Abou Chedid W; Carbin DD; Innes M; Casson H; Broe M; Hossain M; Frajkoulis G; Whiting D; Adamou C; Kusuma M; Moschonas D; Hicks J; Patil K; Eden C; Perry MJA
J Robot Surg; 2023 Dec; 17(6):2697-2701. PubMed ID: 37548820
[TBL] [Abstract] [Full Text] [Related]
14. ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.
Tutrone R; Lowentritt B; Neuman B; Donovan MJ; Hallmark E; Cole TJ; Yao Y; Biesecker C; Kumar S; Verma V; Sant GR; Alter J; Skog J
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):596-601. PubMed ID: 37193776
[TBL] [Abstract] [Full Text] [Related]
15. Staging accuracy of MRI of the prostate with special reference to the influence of the time of last ejaculation on the detection of seminal vesicle invasion.
Blasi F; Malouhi A; Cho CH; Nißler D; Berger FP; Grimm MO; Abubrig M; Teichgräber U; Franiel T
Clin Radiol; 2023 May; 78(5):e425-e432. PubMed ID: 36849278
[TBL] [Abstract] [Full Text] [Related]
16. Heterogeneity of [
Pan J; Zhao J; Ni X; Zhu B; Hu X; Wang Q; Wei Y; Zhang T; Gan H; Wang B; Wu J; Song S; Liu C; Ye D; Zhu Y
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1822-1832. PubMed ID: 36719427
[TBL] [Abstract] [Full Text] [Related]
17. PI-RADS
Yu R; Jiang KW; Bao J; Hou Y; Yi Y; Wu D; Song Y; Hu CH; Yang G; Zhang YD
Br J Cancer; 2023 Apr; 128(6):1019-1029. PubMed ID: 36599915
[TBL] [Abstract] [Full Text] [Related]
18. The impact of prostate biopsy on erectile and ejaculatory function: A prospective study.
Morelli M; Sampogna G; Molteni S; Sciorio C; Lorusso V; Romano L; La Rocca R; Capece M; Zimarra A; Napolitano L; Verze P; Spirito L
Arch Ital Urol Androl; 2022 Dec; 94(4):420-423. PubMed ID: 36576472
[TBL] [Abstract] [Full Text] [Related]
19. Combining clinical parameters and multiparametric magnetic resonance imaging to stratify biopsy-naïve men for an optimum diagnostic strategy with prostate-specific antigen 4 ng ml
Zhang CC; Tu X; Lin TH; Cai DM; Yang L; Qiu S; Liu ZH; Yang L; Wei Q
Asian J Androl; 2023; 25(4):492-498. PubMed ID: 36571328
[TBL] [Abstract] [Full Text] [Related]
20. Global burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis.
Huang J; Chan CK; Yee S; Deng Y; Bai Y; Chan SC; Tin MS; Liu X; Lok V; Zhang L; Xu W; Zheng ZJ; Teoh JY; Ng CF; Wong MCS
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):421-428. PubMed ID: 36414786
[TBL] [Abstract] [Full Text] [Related]
[Next]
